250
Participants
Start Date
July 1, 2024
Primary Completion Date
May 31, 2027
Study Completion Date
December 31, 2027
Supportive care
The study model will utilize the accepted standard of care while implementing key enhancements to proactively reach high-risk patients as early as possible. Wrap around comprehensive care is defined as database screening, outreach, encouraging genetic testing for participants and their family members, and provide ongoing education, medical management (e.g., adherence to FDA-approved medications), routine laboratory testing, specialist referrals, Epic referrals to integrated care support such as pharmacy, nutrition, social work, and community health), and routine follow-up either in-person or using virtual visits. Consultations with pharmacists, nutritionists and genetic counselors or specialists to manage co-morbidities may be requested.
NOT_YET_RECRUITING
Atlantic Medical Group, Clark
RECRUITING
Atlantic Medical Group, Springfield
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Atlantic Health System
OTHER